Keeley Teton Advisors LLC grew its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,436,283 shares of the real estate investment trust’s stock after acquiring an additional 41,391 shares during the quarter. Sabra Healthcare REIT comprises approximately 1.7% of Keeley Teton Advisors LLC’s investment portfolio, making the stock its 9th biggest position. Keeley Teton Advisors LLC owned about 0.81% of Sabra Healthcare REIT worth $31,512,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of SBRA. Bank of New York Mellon Corp increased its stake in shares of Sabra Healthcare REIT by 294.2% in the 3rd quarter. Bank of New York Mellon Corp now owns 4,721,303 shares of the real estate investment trust’s stock worth $103,586,000 after acquiring an additional 3,523,631 shares during the last quarter. Anchor Capital Advisors LLC acquired a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth $40,616,000. APG Asset Management US Inc. increased its stake in shares of Sabra Healthcare REIT by 160.6% in the 3rd quarter. APG Asset Management US Inc. now owns 2,874,000 shares of the real estate investment trust’s stock worth $63,056,000 after acquiring an additional 1,771,033 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Sabra Healthcare REIT by 151.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,405,450 shares of the real estate investment trust’s stock worth $52,774,000 after acquiring an additional 1,450,287 shares during the last quarter. Finally, Numeric Investors LLC acquired a new stake in shares of Sabra Healthcare REIT in the 2nd quarter worth $30,450,000. 85.51% of the stock is owned by institutional investors and hedge funds.

A number of analysts recently issued reports on SBRA shares. TheStreet downgraded Sabra Healthcare REIT from a “b-” rating to a “c” rating in a research report on Friday, November 3rd. Capital One Financial started coverage on Sabra Healthcare REIT in a research report on Monday, September 25th. They set an “equal weight” rating and a $24.00 price objective for the company. Zacks Investment Research downgraded Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research report on Wednesday, October 25th. Bank of America raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “underperform” rating in a research report on Friday, September 8th. Finally, Mizuho raised Sabra Healthcare REIT from an “underperform” rating to a “neutral” rating and raised their price objective for the stock from $23.00 to $24.00 in a research report on Monday, September 11th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $24.40.

Sabra Healthcare REIT, Inc. (NASDAQ SBRA) opened at $19.00 on Wednesday. The firm has a market capitalization of $3,440.00, a PE ratio of 8.50, a price-to-earnings-growth ratio of 2.52 and a beta of 0.92. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.66 and a quick ratio of 1.66. Sabra Healthcare REIT, Inc. has a 52-week low of $18.48 and a 52-week high of $29.10.

The company also recently announced a quarterly dividend, which was paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th were given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 1.47%. The ex-dividend date was Tuesday, November 14th. Sabra Healthcare REIT’s dividend payout ratio is currently 266.67%.

In other Sabra Healthcare REIT news, Director Milton J. Walters sold 4,615 shares of Sabra Healthcare REIT stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $19.18, for a total value of $88,515.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 2.60% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Sabra Healthcare REIT, Inc. (SBRA) Shares Bought by Keeley Teton Advisors LLC” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.thecerbatgem.com/2017/12/06/sabra-healthcare-reit-inc-sbra-shares-bought-by-keeley-teton-advisors-llc.html.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Stock Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related stocks with our FREE daily email newsletter.